scispace - formally typeset
C

Charles L. Edelstein

Researcher at University of Colorado Denver

Publications -  187
Citations -  26548

Charles L. Edelstein is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Acute kidney injury & Kidney. The author has an hindex of 69, co-authored 183 publications receiving 22853 citations. Previous affiliations of Charles L. Edelstein include University of Colorado Boulder & Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery.

TL;DR: Interleukin-18 is an early, predictive biomarker of AKI after CPB, and that NGAL and IL-18 are increased in tandem afterCPB, suggesting the combination of these two biomarkers may allow for the reliable early diagnosis and prognosis ofAKI at all times after CPBs.